Isuprel (Hospira, Inc.)
Welcome to the PulseAid listing for the Isuprel drug offered from Hospira, Inc.. This Adrenergic beta-Agonists [MoA],beta-Adrenergic Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Hospira, Inc. |
NON-PROPRIETARY NAME: | ISOPROTERENOL HYDROCHLORIDE |
SUBSTANCE NAME: | ISOPROTERENOL HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Adrenergic beta-Agonists [MoA],beta-Adrenergic Agonist [EPC] |
ROUTE: | INTRACARDIAC; INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2013-03-21 |
END MARKETING DATE: | 0000-00-00 |
Isuprel HUMAN PRESCRIPTION DRUG Details:
Item Description | Isuprel from Hospira, Inc. |
LABELER NAME: | Hospira, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 0.2(mg/mL) |
START MARKETING DATE: | 2013-03-21 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0409-1442_ccb8f8a1-d89f-46d9-a5d1-0e8bafca27fb |
PRODUCT NDC: | 0409-1442 |
APPLICATION NUMBER: | NDA010515 |
Other ISOPROTERENOL HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: